USANA Health Sciences (NYSE:USNA) Releases Quarterly Earnings Results, Beats Estimates By $0.15 EPS

USANA Health Sciences (NYSE:USNA) announced its earnings results on Tuesday. The company reported $0.64 EPS for the quarter, topping the consensus estimate of $0.49 by $0.15, Zacks reports. The business had revenue of $213.61 million for the quarter, compared to the consensus estimate of $208.82 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. USANA Health Sciences updated its FY 2025 guidance to 2.350-3.000 EPS.

USANA Health Sciences Stock Down 11.5 %

NYSE:USNA traded down $3.82 during trading hours on Thursday, hitting $29.39. 91,313 shares of the stock were exchanged, compared to its average volume of 150,236. The company’s 50 day moving average is $33.62 and its two-hundred day moving average is $36.61. USANA Health Sciences has a twelve month low of $29.50 and a twelve month high of $50.32. The company has a market capitalization of $560.19 million, a P/E ratio of 10.44, a price-to-earnings-growth ratio of 0.93 and a beta of 0.87.

Analyst Ratings Changes

Several research analysts have recently commented on USNA shares. Sidoti downgraded USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a report on Tuesday, February 18th. DA Davidson upped their price objective on USANA Health Sciences from $35.00 to $38.00 and gave the stock a “neutral” rating in a report on Thursday, January 2nd. Finally, StockNews.com downgraded USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a report on Friday, February 14th.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.